Search research articles
Contact Us
Filters
Showing results (181-190 of 1,084) with videos related to
Page
of 109
Sort By:
European Neurology
|
June 20, 2014
Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice
Peter Flachenecker, Thomas Henze, Uwe K Zettl
Pharmaceutics
|
January 26, 2024
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl
Acta Neurologica Scandinavica
|
November 22, 2013
Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life
P Flachenecker, T Henze, U K Zettl
Archiv Der Pharmazie
|
November 27, 2010
Functionalization of fatty acid mimetics for solid-phase coupling and subsequent target identification
Michaela Dittrich, Heiko Zettl, Manfred Schubert-Zsilavecz
Autoimmunity Reviews
|
June 14, 2015
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
Brit Fitzner, Michael Hecker, Uwe Klaus Zettl
Journal of Neurology
|
May 16, 2007
Coping with neuroimmunological diseases
Thomas Klauer, Wolfgang Schneider, Uwe K Zettl
Journal of Neurology
|
May 16, 2007
Complementary and alternative medicine and coping in neuroimmunological diseases
A Apel, B Greim, U K Zettl
Advanced Materials (Deerfield Beach, Fla.)
|
May 7, 2015
Atomic Defects in Two Dimensional Materials
Haider I Rasool, Colin Ophus, Alex Zettl
Biology of Sex Differences
|
May 29, 2019
Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Journal of Immunology (Baltimore, Md. : 1950)
|
April 10, 2019
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Nina Boxberger, Michael Hecker, Uwe K Zettl
Page
of 109
Search research articles
Search
Showing results (181-190 of 1,084) with videos related to
Sort By:
Page
of 109
European Neurology
|
June 20, 2014
Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice
Peter Flachenecker, Thomas Henze, Uwe K Zettl
Pharmaceutics
|
January 26, 2024
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl
Acta Neurologica Scandinavica
|
November 22, 2013
Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life
P Flachenecker, T Henze, U K Zettl
Archiv Der Pharmazie
|
November 27, 2010
Functionalization of fatty acid mimetics for solid-phase coupling and subsequent target identification
Michaela Dittrich, Heiko Zettl, Manfred Schubert-Zsilavecz
Autoimmunity Reviews
|
June 14, 2015
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
Brit Fitzner, Michael Hecker, Uwe Klaus Zettl
Journal of Neurology
|
May 16, 2007
Coping with neuroimmunological diseases
Thomas Klauer, Wolfgang Schneider, Uwe K Zettl
Journal of Neurology
|
May 16, 2007
Complementary and alternative medicine and coping in neuroimmunological diseases
A Apel, B Greim, U K Zettl
Advanced Materials (Deerfield Beach, Fla.)
|
May 7, 2015
Atomic Defects in Two Dimensional Materials
Haider I Rasool, Colin Ophus, Alex Zettl
Biology of Sex Differences
|
May 29, 2019
Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Journal of Immunology (Baltimore, Md. : 1950)
|
April 10, 2019
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
Nina Boxberger, Michael Hecker, Uwe K Zettl
Page
of 109